Table 4 |
||||||
|
Summary of events during follow-upa |
||||||
|
Event |
RA + CAD (n = 75), n (%) |
CAD (n = 128), n (%) |
Unadjusted HR (95% CI) |
P |
Adjusted HRb (95% CI) |
P |
|
|
||||||
|
CV death |
13 (17) |
9 (7) |
2.22 (0.95, 5.20) |
0.06 |
1.94 (0.80, 4.69) |
0.14 |
|
Death |
24 (32) |
23 (18) |
1.63 (0.92, 2.89) |
0.10 |
1.29 (0.72, 2.32) |
0.39 |
|
CABG during follow-up |
18 (24) |
34 (27) |
0.87 (0.49, 1.53) |
0.62 |
0.80 (0.44, 1.44) |
0.45 |
|
MI during follow-up |
28 (37) |
43 (34) |
1.08 (0.67, 1.73) |
0.77 |
0.79 (0.48, 1.28) |
0.34 |
|
PTCR during follow-up |
27 (36) |
47 (37) |
0.78 (0.43, 1.41) |
0.41 |
0.69 (0.37, 1.27) |
0.23 |
|
Any event |
53 (71) |
88 (69) |
1.19 (0.84, 1.68) |
0.34 |
1.05 (0.73, 1.50) |
0.81 |
|
|
||||||
|
aRaw counts and Cox model results for various follow-up endpoints. bAdjusted models include number of vessels and hyperlipidemia in the model as covariates. CABG, coronary artery bypass surgery; CAD, coronary artery disease; CI, confidence interval; CV, cardiovascular; HR, hazard ratio; MI, myocardial infarction; PTCR, percutaneous transluminal coronary. |
||||||
|
Warrington et al. Arthritis Research & Therapy 2005 7:R984 doi:10.1186/ar1775 |
||||||
